AvenCell
AvenCell develops next generation immunotherapies against hard-to-treat blood and solid tumor cancers.
HQ location
Cambridge, United States
Website
Enterprise value
$448—672m
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads